|
Volumn 71, Issue 2, 2014, Pages 400-401
|
Effect of the endothelin type A-selective endothelin receptor antagonist ambrisentan on digital ulcers in patients with systemic sclerosis: Results of a prospective pilot study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMBRISENTAN;
BOSENTAN;
CLINICAL ARTICLE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FINGER ULCER;
HUMAN;
LETTER;
MALE;
OPEN STUDY;
PERIPHERAL EDEMA;
PILOT STUDY;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
SYSTEMIC SCLEROSIS;
ULCER HEALING;
ADULT;
FEMALE;
FINGERS;
HUMANS;
MALE;
MIDDLE AGED;
PHENYLPROPIONATES;
PILOT PROJECTS;
PROSPECTIVE STUDIES;
PYRIDAZINES;
RECEPTOR, ENDOTHELIN A;
SCLERODERMA, SYSTEMIC;
SKIN ULCER;
|
EID: 84904612564
PISSN: 01909622
EISSN: 10976787
Source Type: Journal
DOI: 10.1016/j.jaad.2014.04.028 Document Type: Article |
Times cited : (23)
|
References (4)
|